1. McCurdy, L.H., Larkin, B.D., Martin, J.E. & Graham, B.S.

Modified vaccinia
Ankara: potential as an alternative smallpox vaccine. Clin. Infect. Dis. 38,
1749–1753 (2004).

PubMed Article Google Scholar 

2. 83

WHO collaborative study group: The relationship between persisting spinal

paralysis and poliomyelitis vaccine—results of a ten-year enquiry. Bull
WHO 60, 231–242 (1982).

3. 84

Hoft, D.F. et al. Clinical reactogenicity of intradermal bacille Calmette-Guerin

vaccination. Clin. Infect. Dis. 28, 785–790 (1999).
CAS PubMed Article Google Scholar 

4. 85

Horwitz, M.A. & Harth, G. A new vaccine against tuberculosis affords greater
survival after challenge than the current vaccine in the guinea pig model of
pulmonary tuberculosis. Infect. Immun. 71, 1672–1679 (2003).
CAS PubMed PubMed Central Article Google Scholar 

5. 86

Morse, S.S. The viruses of the future? Emerging viruses and evolution. in The
Evolutionary Biology of Viruses (ed Morse, S.S.) 325–335 (Raven Press, New
York, 1994).
Google Scholar 
10. Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al.
Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med.
2020;383(27):2603-15.
11. Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy
and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med.
2021;384(5):403-16.
12. Mahase E. Covid-19: Pfizer vaccine efficacy was 52% after first dose and 95%
after second dose, paper shows.
13. Voysey M, Clemens SA, Madhi SA, Weckx LY, Folegatti PM, Aley PK, et al.
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-
CoV-2: an interim analysis of four randomised controlled trials in Brazil, South
Africa, and the UK. Lancet. 2021;397(10269):99-111.
16. Callaway E. Oxford covid vaccine results puzzle scientists. Nature. 2020;588.
18. Voysey M, Clemens SA, Madhi SA, Weckx LY, Folegatti PM, Aley PK, et al.
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-
CoV-2: an interim analysis of four randomised controlled trials in Brazil, South
Africa, and the UK. Lancet. 2021;397(10269):99-111.
19. Knoll MD, Wonodi C. Oxford–AstraZeneca COVID-19 vaccine efficacy.
Lancet. 2021;397(10269):72-4.
20. Palacios R, Patiño EG, de Oliveira Piorelli R, Conde MT, Batista AP, Zeng G,
et al. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to
Evaluate the Efficacy and Safety of treating Healthcare Professionals with the
Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac–PROFISCOV:
A structured summary of a study protocol for a randomised controlled trial. Trials.
2020;21(1):1-3.
21. Cohen J. Vaccine designers take first shots at COVID-19.
Rowland  C, Johnson  CY, Wan  W. Even finding a COVID-19 vaccine won’t be enough
to end the pandemic. Washington Post. May 11, 2020. Accessed May 13,
2020. https://www.washingtonpost.com/business/2020/05/11/coronavirus-vaccine-
global-supply/
2.
Sanche  S, Lin  YT, Xu  C, Romero-Severson  E, Hengartner  N, Ke  R.  High
contagiousness and rapid spread of severe acute respiratory syndrome coronavirus
2.    Emerg Infect Dis. 2020;26(7). doi:10.3201/eid2607.200282PubMedGoogle Scholar
3.
Trujillo  KL, Motta  M. A majority of vaccine skeptics plan to refuse a COVID-19 vaccine,
a study suggests, and that could be a big problem. Published May 4, 2020. Accessed
May 6, 2020. https://theconversation.com/a-majority-of-vaccine-skeptics-plan-to-refuse-
a-covid-19-vaccine-a-study-suggests-and-that-could-be-a-big-problem-137559
4.
LX/Morning Consult.  National Tracking Poll #200395: March 24-25, 2020. LX/Morning
Consult; 2020.
5.
Edwards  KM, Hackell  JM; Committee on Infectious Diseases, the Committee on
Practice and Ambulatory Medicine.  Countering vaccine hesitancy.    Pediatrics.
2016;138(3):2016-2146. doi:10.1542/peds.2016-2146
https://www.dovepress.com/getfile.php?fileID=70816

https://maplespub.com/article/COVID-19-Vaccination-Efficacy-and-Safety-Literature-Review

file:///C:/Users/tely_/Downloads/NjauJDandCairnsLisaK2016.pdf
https://www.nature.com/articles/nm1209

https://www.pnas.org/content/118/10/e2021726118

https://doh.gov.ph/sites/default/files/basic-page/The%20Philippine%20National%20COVID-
19%20Vaccination%20Deployment%20Plan.pdf